Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15d42f684941d5b0617ca7764ebdff07 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 |
filingDate |
2014-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52d17fe3ef7db92565fd5277b98acacc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92f50267d534cf2896914c582f0e98dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ce4802f445fcef7407307d523de9030 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4415d1ee734fe6a86e099c2b2b06264a |
publicationDate |
2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2014256375-A1 |
titleOfInvention |
Administering antisense oligonucleotide complementary to human apolipoprotein b |
abstract |
Pharmaceutical compositions and methods for long-term lowering of lipid levels in human subjects and for the treatment of conditions associated with elevated LDL-cholesterol and elevated ApoB are provided. |
priorityDate |
2007-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |